GPX4 and acute myeloid leukemia: Similarly, neratinib induces ferroptosis in acute myeloid leukemia (AML) cells, which is characterized by increased ROS and malondialdehyde content, enhanced Fe2+ activity, and downregulated GPX4 and ferritin heavy chain 1 expression [31].